Kevin Robert Lind - Aug 12, 2024 Form 4 Insider Report for Longboard Pharmaceuticals, Inc. (LBPH)

Role
CEO, Director
Signature
/s/ Andrew J. Cronauer, Attorney-In-Fact
Stock symbol
LBPH
Transactions as of
Aug 12, 2024
Transactions value $
$259,995
Form type
4
Date filed
8/13/2024, 06:03 PM
Previous filing
Feb 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LBPH Common Stock Options Exercise $251K +80.3K +23.03% $3.12 429K Aug 12, 2024 Direct
transaction LBPH Common Stock Options Exercise $9.31K +2.22K +0.52% $4.20 431K Aug 12, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LBPH Stock Option (Right to Buy) Options Exercise $0 -80.3K -23.03% $0.00 268K Aug 12, 2024 Common Stock 80.3K $3.12 Direct F1
transaction LBPH Stock Option (Right to Buy) Options Exercise $0 -2.22K -1.14% $0.00 193K Aug 12, 2024 Common Stock 2.22K $4.20 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the stock option vest and become exercisable in 24 equal monthly installments commencing November 27, 2022.
F2 The shares subject to the stock option vest and become exercisable in 48 equal monthly installments commencing March 9, 2023.